D-Penicillamine-induced pemphigus syndrome
| Autor: | George W. Hambrick, Cheuk W. Yung |
|---|---|
| Rok vydání: | 1982 |
| Předmět: |
Male
medicine.medical_specialty Arthritis Dermatology Polymyositis Arthritis Rheumatoid immune system diseases medicine Humans skin and connective tissue diseases Aged Systemic lupus erythematosus business.industry Penicillamine Pemphigus erythematosus Complement C3 Dermatomyositis medicine.disease Pemphigus Erythema Immunoglobulin G Rheumatoid arthritis business Nephrotic syndrome |
| Zdroj: | Journal of the American Academy of Dermatology. 6:317-324 |
| ISSN: | 0190-9622 |
| Popis: | D-Penicillamine is a chelating agent which is effective in the treatment of Wilson's disease, cystinuria, and lead poisoning. In recent years, it has also been used to treat patients with rheumatoid arthritis with good results. The adverse effects of D-penicillamine are many. These include loss of taste, nephrotic syndrome, lupus erythematosus--like syndrome, polymyositis, dermatomyositis, myasthenia gravis, and agranulocytosis. Beginning in 1969, D-penicillamine was reported to induce a pemphigus eruption. We present a patient with D-penicillamine--induced pemphigus erythematosus and review previously reported cases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|